Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
Muldoon, think you are wrong, it has been reported on numerous sites as Savannah Resources. Just google Savannah Resources Barclays and look at the results. If I am wrong, I apologise.
Barclays started coverage and issued a note yesterday with a 41p price target.
I am sure that the Botswana government must realise that they have messed up by asking for the impossible and I would hope that they make amends by fast tracking the smaller pilot project which was what Tlou wanted in the first place. I do feel sorry for the people at Tlou who have workedso hard on this
Hi Appi, good post, as Paul Gascoine once said. �I never make predictions, and I never will�. But I would be very disappointed if we did not get news of Newfoundland, Alberta or the Far Eat or all three and follow up on on a heap of leads from this week.
I would imagine that if new contracts have been agreed and are being signed in Utah to generate maximum publicity about this week that there could possibly be more announcements this week. Bear in mind the seven hour time difference, it is 2am there at the moment, ao I would not expect news today.
Well I just started reading a book and on page 4 of the prologue a Power Station has in Utah blows up. Not a good omen me thinks, at least the book was written in 2008. Good luck all
I see that Numis have started coverage of Shanta with a buy rating and a 12 pence price target today.
They might notbe sells, the 8.19 sell was a buy.
Excellent news, would be good and perhaps give us a clue if Mr Barder does another interview on Proactive.
Thomad, brings back memories, I bought 25,000 Asos at 7.5p and sold them a week later for 10.5p making around £800, if only I had kept them, or at least kept the profit. I ave a decent investment in Fum and am optimistic about 2018, if I am in doubt I just watch the last two videos on Proactive, either Mr Barder is a liar or good things are just around the corner, I favout the latter. Best wishes to all and good luck next year.
Hi Thoth, yes very quiet, I have been invested here for quite some time and have built up a decent holding. I think that the share is very much under the radar and not very well known. I met most of the directors at the Agm in January and liked what they had to say. There was a trading statement on 21st Oct last year so we could have an update quite soon. Have a look at their Twitter link, a few interesting new positions advertised recently. Good luck.
Great results, great interview with CEO on Proactive. A lot to look forward to.
Cantor Fitzgerald and Whitman Howard reinterate buy recs with price targets of 3 and 2.2
I have been in IOM for about 10 years, the price allways seems to drop on results then recovers and icreases over the next few weeks, just have patience.
Says - Bill reports a terrific set of figures and outlook this morning. EPS for YE12/16 were 4 usd cents. That is 3p. The share price is now 5p offer. That is very cheap. Rember : all the disputes with the FTC are settled.
Hi Goldust, i do not think that there are too many shares freely available, which will work well if we have good news and as you say the reverse if we have bad news, I think that someone had been selling for the past few months and this brought the price down. I feel that the price should be a bit higher yet and I am hoping that we get news of improved trading due to revenue from the trials announced lasy year building. I was expecting a trading statement this week as it was announced on 19th Oct last year but may have been delayed as Dereck Hill is addressing the conference in Washington and he would probably prefer to be here.
I like it Dereck Hill is presenting at The Coalition Against Major Diseases in Washington, he commented. Biosensor technologies are set to revolutionise drug development and patient care when used in the appropriate clinical context and regulatory framework. Ixico is delighted to share our cutting-edge work with regulators and experts in the pharmaceutical industry.
Eck announced on 27th July that Adam Molony, CFO had resigned and would leave when a successor was found. So it is hardly surprising that he is cashing in his options and selling before he leaves. He did 13 years as CFO so good luck to him and thanks for helping to take the share price from a few pence to where it is today.
Another nice contract announced today. There was a trading statement on 19th Oct last year so lets hope for more news next week. Prior to this they had nine early stage contracts so revenue should be building.
Someone selling, it does not take many to push the price down, also it does not take many to push the price up. Should be a trading statement in about a month, early stage of nine trials with revenue building and a great announcement today, liked the last bit on RNS, prior to production rollout. Working with Biogen a $66 billion market cap company